MENU

Should you sell your Medibank Private Ltd shares?

At $2.32 per share, retail investors who took part in the Medibank Private Ltd (ASX: MPL) IPO would today be sitting on a whopping paper gain of 16%, since the stock went public just one month ago.

Talk about easy money…

However, at $2.32, Medibank’s valuation is eye-watering. Many astute analysts have placed fair value of Medibank shares around $2.08. Which means the current price has no margin of safety. If your investing for anything less than the long term (five or more years), that’s not great news.

Indeed Medibank shares currently trade on a forward P/E ratio of 24. This compares with the smaller and more profitable NIB Holdings Limited (ASX: NHF) which trades on a P/E ratio of 18.9 and forecast 3.5% fully franked dividend.

In 2015, Medibank will pay just 4.9 cents per share as a dividend. That’s a cash return equivalent to just 2.1%.

Of course, based on 2016 forecasts, its yield jumps to 3.5%.

Still it’s hardly impressive. Especially when we consider the share prices of companies with lofty valuations are more susceptible to sell offs at the first sign of weakness.

Now, if you think I’m being a little hard on Medibank. See my disclosure below, I own shares.

And for what it’s worth, I hope its current valuation holds up (and goes higher!), but with the market – aka the S&P/ASX 200 (ASX: XJO) (INDEX: ^AXJO) – trading on a P/E slightly below 14, a return to the mean won’t be pretty for Medibank.

Foolish takeaway

When one of our stocks goes meaningfully higher, it can be easy to fall in the love with it.

At its current valuation, Medibank is not a sound investment. And unless you intend to hold your shares for the long term (five years or more), I think now could be the right time to walk away from the table, at least in part. I’m certainly considering it.

Our #1 stock idea for 2015 is a much better BUY than Medibank Private

The Motley Fool's top stock for 2015 is a sexy ASX tech company with a stunning track record and plenty of room to run. Discover our analysts' hands-down favourite bet for 2015 in this brand-new FREE report. Simply click here to grab your copy.

Motley Fool Contributor Owen Raszkiewicz owns shares of Medibank Private and NIB Holdings. You can follow Owen on Twitter @ASXinvest.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.